Search Results - "WINN, AARON N."

Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia by DUSETZINA, Stacie B, WINN, Aaron N, ABEL, Gregory A, HUSKAMP, Haiden A, KEATING, Nancy L

“…The introduction of imatinib, a tyrosine kinase inhibitor (TKI), has greatly increased survival for patients with chronic myeloid leukemia (CML). Conversely,…”
Get full text

Untangling the Black-White mortality gap in endometrial cancer: a cohort simulation by Doll, Kemi M., MD, MSCR, Winn, Aaron N., MPP, Goff, Barbara A., MD

Get full text

Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence by Zhong, Yue, MD, PhD, Lin, Pei-Jung, PhD, Cohen, Joshua T., PhD, Winn, Aaron N., MPP, Neumann, Peter J., ScD

“…Abstract Objectives To systematically review the cost-effectiveness of diabetes interventions, identify high-value diabetes services, and estimate potential…”
Get full text

The cost, survival, and quality‐of‐life implications of guideline‐discordant imaging for prostate cancer by Winn, Aaron N., Kelly, Matthew, Ciprut, Shannon, Walter, Dawn, Gold, Heather T., Zeliadt, Steven B., Sherman, Scott E., Makarov, Danil V.

“…Background National Comprehensive Cancer Network (NCCN) guidelines for incident prostate cancer staging imaging have been widely circulated and accepted as…”
Get full text

Cost-Utility Analysis of Cancer Prevention, Treatment, and Control by Winn, Aaron N., MPP, Ekwueme, Donatus U., PhD, Guy, Gery P., PhD, Neumann, Peter J., ScD

“…Context Substantial innovation related to cancer prevention and treatment has occurred in recent decades. However, these innovations have often come at a…”
Get full text

Twenty-first century house calls: a survey of ambulatory care providers to inform organisational telehealth strategy by Holt, Jeana M, Cusatis, Rachel, Mortensen, Natalie, Wolfrath, Nathan, Hyun, Noorie, Winn, Aaron N, Brown, Sherry-Ann, Somai, Melek M, Crotty, Bradley H

“…While patient interest in telehealth increases, clinicians' perspectives may influence longer-term adoption. We sought to identify facilitators and barriers to…”
Get full text

Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis by Doll, Kemi M., Winn, Aaron N.

“…Commonly reported incidence rates for endometrial cancer fail to take into account both the large number of hysterectomies performed each year and the dynamic…”
Get full text

Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia by Winn, Aaron N, Keating, Nancy L, Dusetzina, Stacie B

“…Purpose There is substantial concern surrounding affordability of orally administered anticancer therapies, particularly for Medicare beneficiaries. We…”
Get full text

Clinician burnout during the COVID-19 pandemic before vaccine administration by Bakken, Brianne K., Winn, Aaron N.

“…Coronavirus disease 2019 (COVID-19) has disrupted pharmacy practice. Little research has been done to assess how COVID-19 has affected pharmacists’ employment,…”
Get full text

Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries by Mitchell, Aaron P, Winn, Aaron N, Dusetzina, Stacie B

Get more information

Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ by Anderson, Chelsea, Winn, Aaron N., Dusetzina, Stacie B., Nichols, Hazel B.

“…Background. Although treatment of ductal carcinoma in situ (DCIS) is controversial, national guidelines recommend considering endocrine therapy for women with…”
Get full text

Racial and Ethnic Differences in Medication Initiation Among Adults Newly Diagnosed with Type 2 Diabetes by Gopalan, Anjali, Winn, Aaron N., Karter, Andrew J., Laiteerapong, Neda

“…Objective Given persistent racial/ethnic differences in type 2 diabetes outcomes and the lasting benefits conferred by early glycemic control, we examined…”
Get full text

First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists by Laiteerapong, Neda, Alexander, Jason, Philipson, Louis, Winn, Aaron N, Huang, Elbert S

Get full text

Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study by Mitchell, Aaron P, Dusetzina, Stacie B, Mishra Meza, Akriti, Trivedi, Niti U, Bach, Peter B, Winn, Aaron N

“…To estimate the association between oncologists' receipt of payments from the pharmaceutical industry and delivery of non-recommended or low value…”
Get more information

First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study by Choi, Jin G, Winn, Aaron N, Skandari, M Reza, Franco, Melissa I, Staab, Erin M, Alexander, Jason, Wan, Wen, Zhu, Mengqi, Huang, Elbert S, Philipson, Louis, Laiteerapong, Neda

“…Guidelines recommend sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists as second-line therapy for patients…”
Get full text

New‐onset persistent opioid use following breast cancer treatment in older adult women by Roberts, Andrew W., Fergestrom, Nicole, Neuner, Joan M., Winn, Aaron N.

“…Background Patients with cancer‐related pain are underrepresented in the opioid literature despite high opioid exposure and numerous risk factors for adverse…”
Get full text

The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer by Winn, Aaron N., Dusetzina, Stacie B.

“…Purpose Studies examining adherence to endocrine therapy (ET) and breast cancer‐related outcomes have traditionally used the proportion of days covered (PDC)…”
Get full text

Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology by Mitchell, Aaron P., Winn, Aaron N., Lund, Jennifer L., Dusetzina, Stacie B.

“…Background Financial relationships between physicians and the pharmaceutical industry are common, but factors that may determine whether such relationships…”
Get full text

Association of Use of Online Symptom Checkers With Patients' Plans for Seeking Care by Winn, Aaron N, Somai, Melek, Fergestrom, Nicole, Crotty, Bradley H

“…This cross-sectional study examines the association of patient use of a free online symptom checker tool with patient plans for seeking medical care…”
Get full text

Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review by Winn, Aaron N, Ekwueme, Donatus U, Guy, Jr, Gery P, Neumann, Peter J

“…Substantial innovation related to cancer prevention and treatment has occurred in recent decades. However, these innovations have often come at a significant…”
Get full text